CACrown ArchivesThe cinema collection
Menu
Research dossier · General Reference

Immunotherapy

therapy to elicit or amplify an immune response

Cross-disciplinary reference desk with index cards, atlas, dictionary and catalogue
General referenceInterpretive dossier study · Crown Archives visual atlas
Record originEnglish Wikipedia
Text licenseCC BY-SA 4.0
Source revisionSep 22, 2026
Entity authorityQ1427096
Source-derived summary

Immunotherapy, also known as biological therapy or biotherapy, encompasses a diverse set of therapeutic strategies that harness or modify the immune system to prevent, control, or eliminate disease. In its narrowest definition, immunotherapy refers to treatments designed to stimulate or guide the immune system to recognize and fight cancer, often by enhancing or restoring immune responses to eradicate malignant cells while sparing healthy tissue.

A broader definition of immunotherapy applies beyond oncology, including strategies to stimulate or suppress immune activity against other diseases such as autoimmune disorders, infectious diseases, and allergies. These approaches may involve vaccines, immune modulators, or monoclonal antibodies designed to alter immune responses, either to boost protection against pathogens or to reduce damaging inflammation.

Immunotherapy includes both passive methods, like monoclonal antibodies that mark abnormal cells for immune destruction, and active methods, such as cancer vaccines, immune checkpoint inhibitors, adoptive cell transfer, and cytokine therapies. Advances in immunotherapy have transformed the treatment landscape for cancer and are increasingly applied to a wider range of conditions, improving outcomes for many patients, though responses can vary depending on disease type, genetic background, and environmental factors.

Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells, and cytotoxic T lymphocytes work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells. Vaccine-induced immunity to COVID-19 relies mostly on an immunomodulatory T-cell response.

Therapies such as granulocyte colony-stimulating factor (G-CSF), interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use.

Editorial summary

The public source identifies “Immunotherapy” as therapy to elicit or amplify an immune response. This brief keeps that definition visible, then builds a research path around Immunotherapy, therapy and elicit.

Editorial reviewA dependable orientation record for establishing vocabulary, names and a first evidence trail. The current 259-word lead offers orientation but no explicit four-digit date, so chronology should not be assumed. The selected authority fields contribute no independent date. Its value is orientation rather than verdict, with Immunotherapy, therapy and elicit providing the first useful test.
Editorial analysis

Why this record matters

A short description can identify a subject without explaining its stakes. For “Immunotherapy”, the useful work is to connect “therapy to elicit or amplify an immune response” to the records capable of establishing context and consequence.

Evidence profile

Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Sep 22, 2026. The linked authority identifier is Q1427096. None of the 0 selected statements returned an explicit reference.

Critical limits

The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.

How to read it

Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.

Best used for
  • Subject orientation
  • Search vocabulary
  • Locating named sources
Verify next

The closest primary source, responsible institution and strongest cited specialist reference.

Three-step research path

  1. Establish the record: confirm the title “Immunotherapy”, its source revision and the description used here.
  2. Expand the search: follow Immunotherapy primary sources, Immunotherapy archive and Immunotherapy research across catalogues and specialist indexes.
  3. Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.

Questions for further research

  1. Which source most directly establishes the central claim about “Immunotherapy”?
  2. Which cited source is closest to the event, object or claim?
  3. Which institution is responsible for the underlying evidence?
Subject index

Search terms from this dossier

Source & attribution

This entry incorporates text from Immunotherapy” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.